EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacological Activation of TGR5 Alleviates Cancer-Related Fatigue by Promoting Oxidative Myofiber Remodeling via CREB-Dependent NOR-1 Signaling

Guotao Chen, Liufang Hu, Pei Lin, Qi Wang, Yixuan Jiang, Jiankun Xu, Ling Qin, Xinluan Wang, Xinsheng Yao, Frank J. Gonzalez, Liangliang He, Zhihong Yao

Engineering · 2026-11

DOI: 10.1016/j.eng.2026.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineering, 2026-11. Verfasst von Guotao Chen und 11 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-related fatigue (CRF) is a common and debilitating complication of cancer and its treatment, yet effective pharmacological interventions remain limited. Although regular physical activity alleviates CRF by improving skeletal muscle metabolism and function, many patients are unable to sustain exercise. To identify pharmacologically tractable pathways linked to exercise-induced skeletal muscle adaptation, we investigated Takeda G protein-coupled receptor 5 (TGR5) as an exercise-responsive regulator of muscle remodeling and explored its pharmacological relevance in CRF. TGR5 expression was reduced in CRF, and genetic loss- and gain-of-function studies demonstrated that TGR5 promotes mitochondrial function, oxidative myofiber remodeling, and fatigue resistance. Mechanistically, TGR5 activated the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway and promoted CREB-dependent neuron-derived orphan receptor-1 (NOR-1) expression, thereby driving a mitochondrial and oxidative myofiber remodeling program. As TGR5 is a G protein-coupled receptor, ligand discovery is technically challenging due to receptor instability outside the native membrane environment. To address this challenge, we developed a virus-like particle (VLP)-based surface plasmon resonance (SPR) platform that preserves TGR5 in a membrane-mimetic environment and enables ligand screening from complex herbal extracts. Using this platform, we identified and validated cimigenoside as a natural TGR5-targeting lead compound with agonistic activity. Under a preventive/early-intervention dosing regimen, orally administered cimigenoside alleviated CRF-associated phenotypes, accompanied by improved mitochondrial respiration and partial restoration of oxidative fiber composition. Collectively, these findings identify impaired oxidative myofiber remodeling as a feature of CRF and provide pharmacological proof-of-concept evidence that modulation of the TGR5/CREB/NOR-1 axis may represent a potential approach for improving CRF-associated skeletal muscle dysfunction.

Zitieren

APA

Chen, G., Hu, L., Lin, P., Wang, Q., Jiang, Y., Xu, J., Qin, L., Wang, X., Yao, X., Gonzalez, F. J., He, L., & Yao, Z. (2026). Pharmacological Activation of TGR5 Alleviates Cancer-Related Fatigue by Promoting Oxidative Myofiber Remodeling via CREB-Dependent NOR-1 Signaling. Engineering. https://doi.org/10.1016/j.eng.2026.11.006

Vancouver

Chen G, Hu L, Lin P, Wang Q, Jiang Y, Xu J, et al. Pharmacological Activation of TGR5 Alleviates Cancer-Related Fatigue by Promoting Oxidative Myofiber Remodeling via CREB-Dependent NOR-1 Signaling. Engineering. 2026. doi:10.1016/j.eng.2026.11.006

BibTeX
@article{Chen2026,
  author = {Chen, Guotao and Hu, Liufang and Lin, Pei and Wang, Qi and Jiang, Yixuan and Xu, Jiankun and Qin, Ling and Wang, Xinluan and Yao, Xinsheng and Gonzalez, Frank J. and He, Liangliang and Yao, Zhihong},
  title = {Pharmacological Activation of TGR5 Alleviates Cancer-Related Fatigue by Promoting Oxidative Myofiber Remodeling via CREB-Dependent NOR-1 Signaling},
  journal = {Engineering},
  year = {2026},
  doi = {10.1016/j.eng.2026.11.006}
}
Kostenlos starten →